Literature DB >> 24462123

Comparison of dopamine transporter decline in a patient with Parkinson's disease and normal aging effect.

Kenji Ishibashi1, Keiichi Oda2, Kiichi Ishiwata2, Kenji Ishii2.   

Abstract

We report serial dopamine transporter (DAT) positron emission tomography (PET) scanning in a patient with Parkinson's disease (PD). Six months after motor symptom onset, the patient was diagnosed with PD, Hoehn-Yahr stage 1 at age 71, and underwent DAT PET scanning at ages 71, 72, 74, and 75. Volumes-of-interest were placed on the ventral striatum (vST), pre-commissural dorsal caudate (preDCA), post-commissural caudate (postCA), pre-commissural dorsal putamen (preDPU), and post-commissural putamen (postPU); the results were compared to the age-related regression line created by using the data of 16 healthy subjects. For the patient, DAT availability in the vST, preDCA, postCA, preDPU, and postPU at the first scanning was 5.5%, 26.2%, 29.9%, 34.5%, and 60.2% lower, respectively, compared to the age-related regression line. The rates of DAT decline in the vST, preDCA, postCA, preDPU, and postPU were 5.3%, 5.4%, 8.5%, 6.2%, and 7.8% per year, respectively. The postPU is well known to be an initial region of DAT decline and be severely affected throughout the illness. If the decline follows an exponential pattern, in this case, DAT decline in the postPU is speculated to start about 10 years before the motor symptom onset.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  (11)C-CFT; Aging; Dopamine transporter; Parkinson's disease; Positron emission tomography; Striatum

Mesh:

Substances:

Year:  2014        PMID: 24462123     DOI: 10.1016/j.jns.2014.01.015

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

Review 1.  Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.

Authors:  Christopher L German; Michelle G Baladi; Lisa M McFadden; Glen R Hanson; Annette E Fleckenstein
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology.

Authors:  Madelyn C Houser; W Michael Caudle; Jianjun Chang; George T Kannarkat; Yuan Yang; Sean D Kelly; Danielle Oliver; Valerie Joers; Kathleen M Shannon; Ali Keshavarzian; Malú Gámez Tansey
Journal:  Acta Neuropathol Commun       Date:  2021-08-19       Impact factor: 7.801

3.  Prolyl Oligopeptidase Regulates Dopamine Transporter Phosphorylation in the Nigrostriatal Pathway of Mouse.

Authors:  Ulrika H Julku; Anne E Panhelainen; Saija E Tiilikainen; Reinis Svarcbahs; Anne E Tammimäki; T Petteri Piepponen; Mari H Savolainen; Timo T Myöhänen
Journal:  Mol Neurobiol       Date:  2016-12-13       Impact factor: 5.590

4.  Melatonin receptors limit dopamine reuptake by regulating dopamine transporter cell-surface exposure.

Authors:  Abla Benleulmi-Chaachoua; Alan Hegron; Marine Le Boulch; Angeliki Karamitri; Marta Wierzbicka; Victoria Wong; Igor Stagljar; Philippe Delagrange; Raise Ahmad; Ralf Jockers
Journal:  Cell Mol Life Sci       Date:  2018-07-24       Impact factor: 9.261

5.  The Persistent Neurotoxic Effects of Methamphetamine on Dopaminergic and Serotonergic Markers in Male and Female Rats.

Authors:  Lisa M McFadden; Paula L Vieira-Brock
Journal:  Toxicol Open Access       Date:  2016-09-06

6.  Role of upregulation of the KATP channel subunit SUR1 in dopaminergic neuron degeneration in Parkinson's disease.

Authors:  Min Liu; Cui Liu; Xue Xiao; Shuai-Shuai Han; Ming-Xia Bi; Qian Jiao; Xi Chen; Chun-Ling Yan; Xi-Xun Du; Hong Jiang
Journal:  Aging Cell       Date:  2022-04-20       Impact factor: 11.005

Review 7.  Parkinson's disease as a result of aging.

Authors:  Manuel Rodriguez; Clara Rodriguez-Sabate; Ingrid Morales; Alberto Sanchez; Magdalena Sabate
Journal:  Aging Cell       Date:  2015-02-09       Impact factor: 9.304

Review 8.  Ferritinophagy and α-Synuclein: Pharmacological Targeting of Autophagy to Restore Iron Regulation in Parkinson's Disease.

Authors:  Matthew K Boag; Angus Roberts; Vladimir N Uversky; Linlin Ma; Des R Richardson; Dean L Pountney
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

9.  Individual time course of pre- and postsynaptic PET imaging may improve differential diagnosis of Parkinson's disease and multiple system atrophy: a case report.

Authors:  Kenji Ishibashi; Hirofumi Nishina; Kiichi Ishiwata; Kenji Ishii
Journal:  BMC Res Notes       Date:  2015-09-29

10.  CAV-2-Mediated GFP and LRRK2G2019S Expression in the Macaca fascicularis Brain.

Authors:  Carla di Caudo; Ivan Martínez-Valbuena; Iñaki-Carril Mundiñano; Aurelie Gennetier; Maria Hernandez; Mar Carmona-Abellan; Irene Marcilla Garcia; Eric J Kremer; Rosario Luquin
Journal:  Front Mol Neurosci       Date:  2020-03-25       Impact factor: 5.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.